New TAU method delivers therapeutic RNAs exclusively to cancer cells
Researchers at Tel Aviv University have created a new method of transporting RNA-based drugs to a subpopulation of immune cells involved in the inflammation process, and target disease-inflamed cells without causing damage to healthy cells that surround them. The new technology may revolutionize the treatment of cancer and a wide range of diseases and medical… Read More